Close

Barrington Research Downgrades U.S. Physical Therapy (USPH) to Market Perform

Go back to Barrington Research Downgrades U.S. Physical Therapy (USPH) to Market Perform

US Physical Therapy (USPH) Tops Q2 EPS by 2c

August 4, 2016 8:59 AM EDT

US Physical Therapy (NYSE: USPH) reported Q2 EPS of $0.57, $0.02 better than the analyst estimate of $0.55. Revenue for the quarter came in at $90.4 million versus the consensus estimate of $90.01 million.

GUIDANCE:

US Physical Therapy sees FY2016 EPS of $1.90-$1.96, versus the... More